Holen Sie sich die Stockscreener-App
5.3914
3.26%
0.1714
Schlusskurs vom Vortag:
$5.22
Offen:
$5.32
24-Stunden-Volumen:
439.77K
Relative Volume:
1.20
Marktkapitalisierung:
$208.03M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.9118
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+10.68%
1M Leistung:
+71.66%
6M Leistung:
+37.85%
1J Leistung:
+220.83%
1-Tages-Spanne:
$5.2301
$5.45
1-Wochen-Bereich:
$4.81
$5.879
52-Wochen-Spanne:
$1.68
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
5.392 | 201.40M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.43 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.80 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.59 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
330.89 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Measuring Protara Therapeutics Inc.’s beta against major indicesJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
How to forecast Protara Therapeutics Inc. trends using time seriesJuly 2025 Update & Verified Momentum Stock Watchlist - newser.com
Is Protara Therapeutics Inc. stock a safe haven asset2025 Retail Activity & High Yield Stock Recommendations - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policiesQuarterly Profit Report & AI Based Buy and Sell Signals - newser.com
Trend analysis for Protara Therapeutics Inc. this weekSell Signal & AI Based Trade Execution Alerts - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reportsPortfolio Value Summary & AI Based Buy/Sell Signal Reports - newser.com
Will Protara Therapeutics Inc. stock attract more institutional investorsMarket Performance Summary & Weekly Setup with High ROI Potential - newser.com
How institutional ownership impacts Protara Therapeutics Inc. stock2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com
Exit strategy if you’re trapped in Protara Therapeutics Inc.Bond Market & Capital Efficiency Focused Ideas - newser.com
Will Protara Therapeutics Inc. bounce back from current supportJuly 2025 Patterns & Precise Swing Trade Entry Alerts - newser.com
Can a trend reversal in Protara Therapeutics Inc. lead to recoveryMarket Activity Summary & Real-Time Sentiment Analysis - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 2025Quarterly Growth Report & Verified Short-Term Trading Plans - newser.com
Custom watchlist performance reports with Protara Therapeutics Inc.July 2025 Action & Technical Pattern Based Buy Signals - newser.com
Why hedge funds are buying Protara Therapeutics Inc. stockShare Buyback & Verified Momentum Stock Watchlist - newser.com
Protara Therapeutics' (TARA) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Key resistance and support levels for Protara Therapeutics Inc.2025 Price Action Summary & Verified Technical Signals - newser.com
Advanced analytics toolkit walkthrough for Protara Therapeutics Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
Is Protara Therapeutics Inc. stock a contrarian buyProfit Target & Trade Opportunity Analysis - newser.com
Is Protara Therapeutics Inc. showing signs of accumulationWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - newser.com
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Will Protara Therapeutics Inc. stock sustain high P E ratiosSwing Trade & Long-Term Safe Investment Ideas - newser.com
Will Protara Therapeutics Inc. (1KPA) stock see valuation expansion2025 Volume Leaders & Low Risk High Win Rate Stock Picks - newser.com
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Biotech Firm Protara Therapeutics Issues $4.41 Stock Options and RSUs in Key Employee Grant - Stock Titan
JonesTrading Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
Is Protara Therapeutics Inc. forming a reversal pattern2025 Trading Volume Trends & Expert Curated Trade Setup Alerts - newser.com
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Protara Therapeutics Inc-Aktie (TARA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Zummo Jacqueline | Chf Scientific Operations Off |
Mar 26 '25 |
Sale |
4.53 |
21,224 |
96,145 |
98,861 |
1.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):